Nan Fung Group Holdings
Latest statistics and disclosures from Nan Fung Group Holdings's latest quarterly 13F-HR filing:
- Top 5 stock holdings are EVMN, MPLT, LBRX, OCS, INCY, and represent 68.29% of Nan Fung Group Holdings's stock portfolio.
- Added to shares of these 3 stocks: LBRX (+$8.2M), CELC, INSM.
- Started 2 new stock positions in INSM, CELC.
- Reduced shares in these 9 stocks: OCS, MDGL, , REPL, INCY, BCYC, RKLB, BOLT, BSLK.
- Sold out of its positions in BCYC, BSLK, LAB, REPL, RKLB.
- Nan Fung Group Holdings was a net buyer of stock by $423k.
- Nan Fung Group Holdings has $121M in assets under management (AUM), dropping by 8.54%.
- Central Index Key (CIK): 0001782539
Tip: Access up to 7 years of quarterly data
Positions held by Nan Fung Group Holdings consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Portfolio Holdings for Nan Fung Group Holdings
Nan Fung Group Holdings holds 24 positions in its portfolio as reported in the March 2026 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price | |
|---|---|---|---|---|---|---|
| Evommune Com Shs (EVMN) | 27.3 | $33M | 1.4M | 22.99 |
|
|
| Maplight Therapeutics (MPLT) | 16.3 | $20M | 971k | 20.33 |
|
|
| Lb Pharmaceuticals Com Shs (LBRX) | 12.8 | $16M | +110% | 631k | 24.66 |
|
| Oculis Holding Ordinary Shares (OCS) | 7.7 | $9.3M | -31% | 351k | 26.59 |
|
| Incyte Corporation (INCY) | 4.2 | $5.1M | -8% | 54k | 94.12 |
|
| Beone Medicines Sponsored Ads (ONC) | 3.9 | $4.7M | 16k | 296.97 |
|
|
| Rhythm Pharmaceuticals (RYTM) | 3.5 | $4.3M | 49k | 86.97 |
|
|
| Celcuity (CELC) | 2.7 | $3.2M | NEW | 28k | 114.14 |
|
| Ascendis Pharma A/s Sponsored Adr | 2.6 | $3.1M | 14k | 228.73 |
|
|
| Procore Technologies (PCOR) | 2.5 | $3.0M | 53k | 57.00 |
|
|
| Madrigal Pharmaceuticals (MDGL) | 2.4 | $3.0M | -52% | 5.7k | 523.47 |
|
| Kymera Therapeutics (KYMR) | 2.1 | $2.6M | 31k | 83.29 |
|
|
| ACADIA Pharmaceuticals (ACAD) | 1.9 | $2.3M | 103k | 22.26 |
|
|
| Cybin Com New (HELP) | 1.8 | $2.2M | 460k | 4.80 |
|
|
| Argenx Se Sponsored Adr (ARGX) | 1.7 | $2.0M | 2.8k | 730.25 |
|
|
| Revolution Medicines (RVMD) | 1.5 | $1.9M | 19k | 97.25 |
|
|
| Recursion Pharmaceuticals In Cl A (RXRX) | 1.5 | $1.8M | 595k | 3.07 |
|
|
| Insmed Com Par $.01 (INSM) | 0.9 | $1.1M | NEW | 6.6k | 163.52 |
|
| Ishares Ethereum Tr SHS (ETHA) | 0.7 | $800k | 51k | 15.83 |
|
|
| Harmony Biosciences Hldgs In (HRMY) | 0.6 | $758k | 27k | 28.01 |
|
|
| Entrada Therapeutics (TRDA) | 0.5 | $619k | 49k | 12.62 |
|
|
| Ishares Bitcoin Trust Etf Shs Ben Int (IBIT) | 0.5 | $614k | 16k | 38.42 |
|
|
| Rani Therapeutics Hldgs Com Cl A (RANI) | 0.3 | $363k | 494k | 0.73 |
|
|
| Bolt Biotherapeutics Com New (BOLT) | 0.1 | $118k | -49% | 29k | 4.04 |
|
Past Filings by Nan Fung Group Holdings
SEC 13F filings are viewable for Nan Fung Group Holdings going back to 2021
- Nan Fung Group Holdings 2026 Q1 filed May 14, 2026
- Nan Fung Group Holdings 2025 Q4 filed Feb. 13, 2026
- Nan Fung Group Holdings 2025 Q3 filed Nov. 13, 2025
- Nan Fung Group Holdings 2025 Q2 filed Aug. 13, 2025
- Nan Fung Group Holdings 2025 Q1 filed May 14, 2025
- Nan Fung Group Holdings 2024 Q4 filed Feb. 13, 2025
- Nan Fung Group Holdings 2024 Q3 filed Nov. 13, 2024
- Nan Fung Group Holdings 2024 Q2 filed Aug. 13, 2024
- Nan Fung Group Holdings 2024 Q1 filed May 14, 2024
- Nan Fung Group Holdings 2023 Q4 filed Feb. 13, 2024
- Nan Fung Group Holdings 2023 Q3 filed Nov. 13, 2023
- Nan Fung Group Holdings 2023 Q2 filed Aug. 11, 2023
- Nan Fung Group Holdings 2023 Q1 filed May 12, 2023
- Nan Fung Group Holdings 2022 Q4 filed Feb. 13, 2023
- Nan Fung Group Holdings 2022 Q3 filed Nov. 10, 2022
- Nan Fung Group Holdings 2022 Q2 filed Aug. 12, 2022